MYC and Hyperglycemia: The metabolic disturbances and hyperglycemia in diabetic ischemic heart disease might alter the activity of kinases and transcription factors like DNA-PK, CDC2, MYC, SP1, and CREB1, exacerbating cardiac dysfunction.